Canadian Manufacturing

CEM Specialties Inc. receives $2M through the Ontario Together Fund

by CM Staff   

Manufacturing Research & Development Technology / IIoT Public Sector COVID-19 healthcare In Focus Manufacturing Technology

Investment is intended to accelerate CEM's production of COVID-19 detector technology.

Ontario Together Fund assisting manufacturers.

The Ontario government is providing CEM Specialties Inc. $2 million through the Ontario Together Fund to help commercialize and accelerate production of its airborne COVID-19 detector Kontrol BioCloud (BioCloud). This technology will add another layer of protection by monitoring in real time, the air in places where people gather, such as schools, offices, long-term care homes, hospitals, public transit, and manufacturing facilities. The company anticipates that accelerating the production of the BioCloud will create up to 250 direct jobs and up to 750 indirect jobs.

“From day one, Ontario unleashed its innovation and manufacturing might in the fight against COVID-19, with businesses rolling out new innovations and products to help keep the frontlines and the general public safe,” said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. “It’s the creativity and ingenuity of enterprising companies like CEMSI, with its innovative COVID-19 detection technology, that will help Ontario and the rest of the world successfully emerge from this pandemic, while creating hundreds of good jobs for our province’s skilled workers.”

Kontrol BioCloud (BioCloud), developed by CEMSI (a subsidiary of Kontrol Technologies Corp), is a made-in-Ontario real-time COVID-19 detection device that continuously monitors the presence of the SARS-CoV-2 virus in the air. The technology promotes air circulation, monitors air quality and samples continuously for pathogens like viruses, bacteria and fungi. When the presence of the virus is detected, BioCloud provides an alert in the cloud or over a local intranet. CEMSI has received all approvals required to commercialize and produce the technology.

CEMSI will increase production capacity to 20,000 units per month. The product will be manufactured in London with more than 85 per cent of its components produced in the province.


“We want to thank the Ontario government for their support for commercializing and accelerating production of BioCloud,” says Paul Ghezzi, CEO of Kontrol Technologies Corp. “Our CEMSI team has been focused on developing a solution to create safer spaces through the real-time monitoring of SARS-CoV-2. BioCloud seeks to provide an early detection mechanism with a silent alerting system. Just as smoke detectors and carbon monoxide detectors are now part of building safety, we have created BioCloud as an innovative viral detection technology to help get the economy and daily life back closer to normal.”


Stories continue below